Intellectual Property
Mar. 2, 2017
Ruling limits extraterritorial reach of US patents
The question before the Supreme Court was whether the supply of a single component of a multicomponent product constitutes "a substantial portion" of the patented invention. By Aaron Capron and Arpita Bhattacharyya
Aaron Capron
partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
intellectual property
3300 Hillview Ave
Palo Alto , CA 94304-1203
Phone: (650) 849-6680
Fax: (650) 849-6666
Email: aaron.capron@finnegan.com
Santa Clara Univ School of Law
Aaron Capron is a partner at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
With its latest patent-related decision in Life Technologies Corp. v. Promega Corp., the U.S. Supreme Court addressed the extraterritorial reach of U.S. patents under 35 U.S.C. Section 271(f)(1). While U.S. patent rights are generally limited to activities occurring only in the territory of the United States, Section 271(f)(1) provides an exception to this general rule by permitting U.S. patent p...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In